<DOC>
	<DOCNO>NCT02245009</DOCNO>
	<brief_summary>Arrhythmias atria heart common comorbidity patient cardiac rhythm management device , pacemaker implantable cardioverter/defibrillators ( ICD ) . External electrical cardioversion establish method achieve rhythm control ( restore normal sinus rhythm ) patient atrial arrhythmia . Little data safety efficacy external electrical cardioversion patient cardiac rhythm management device exist . Thus , available data safety external electrical cardioversion cardiac rhythm management patient lack statistical power accurately reflect true hazard external electrical cardioversion patient cardiac rhythm management device . The aim systematically include follow patient cardiac rhythm management device present external electrical cardioversion , analyse effect external electrical cardioversion lead device .</brief_summary>
	<brief_title>Safety External Electrocardioversion Device Patients</brief_title>
	<detailed_description>Introduction Atrial arrhythmia common comorbidity patient cardiac rhythm management ( CRM ) device , pacemaker ICD . External electrical cardioversion establish method achieve rhythm control patient atrial arrhythmia . A paucity data safety efficacy external electrical cardioversion patient cardiac rhythm management device exist . Most publication older date predominantly case report case collection . Few prospective study population cardiac rhythm management patient external electrical cardioversion publish recent year . Thus , available data safety external electrical cardioversion cardiac rhythm management patient lack statistical power accurately reflect true hazard external electrical cardioversion patient cardiac rhythm management device . Rationale Electrocardioversion Propofol sedation atrial ventricular tachyarrhythmia establish therapy . It routinely use patient cardiac rhythm management device risk device lead affectation deem low . This assumption currently support substantial current scientific data , mostly rely old report . No large , prospective trial population patient modern cardiac rhythm management device exist . Aim study The aim systematically include follow patient cardiac rhythm management device present external electrical cardioversion , analyse effect external electrical cardioversion lead device . Thereby , provide reliable evidence detect possible SAE low incidence . Furthermore , gather information efficacy recurrence rate population , examine value external electrical cardioversion rhythm control patient .</detailed_description>
	<criteria>Age â‰¥ 18 year Informed , write consent Atrial ventricular arrhythmia indication CV Status post CRM implantation , include CRTD Age &lt; 18 year Patients guardianship mental disorder / disability lead implantation &lt; 4 week prior CV contraindication eCV transoesophageal echocardiographie ( TOE )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>